persantin 200 retard
ingelheim pharmaceuticals (pty) ltd - dipryridamol - capsules - each sustained release capsule contains dipryridamol 200 mg,
asasantin retard 200/25 mg/mg capsules modified release
boehringer ingelheim limited - dipyridamole, acetylsalicylic acid - capsules modified release - 200/25 mg/mg - platelet aggregation inhibitors excl. heparin
asasantin retard 200mg/25mg modified release hard capsules
imbat limited - aspirin; dipyridamole - capsules modified release - 200/25 milligram(s) - platelet aggregation inhibitors excl. heparin; combinations
persantin 10mg/2ml solution for injection ampoules
boehringer ingelheim ltd - dipyridamole - solution for injection - 5mg/1ml
persantin
boehringer ingelheim (nz) ltd - dipyridamole 25mg - tablet - 25 mg - active: dipyridamole 25mg excipient: magnesium stearate - indicated as an adjunct to oral anticoagulation for the prophylaxis of thromboembolism associated with mechanical prosthetic heart valves.
persantin pl 200 perlongets
boehringer ingelheim (nz) ltd - dipyridamole 200mg; - modified release capsule - 200 mg - active: dipyridamole 200mg excipient: acacia acetone dimeticone ethanol gelatin hypromellose hypromellose phthalate iron oxide red iron oxide yellow isopropyl alcohol methacrylic acid copolymer povidone purified talc purified water stearic acid tartaric acid titanium dioxide triacetin
persantin injection 10 mg2 ml
zuellig pharma pte. ltd. - dipyridamole - injection - 10 mg/2 ml - dipyridamole 10 mg/2 ml
persantine solution
glenwood gmbh pharmazeutische erzeugnisse - dipyridamole - solution - 5mg - dipyridamole 5mg - miscellaneous vasodilatating agents
asasantin retard 200/25 mg/mg capsules modified release
primecrown 2010 ltd - dipyridamole, acetylsalicylic acid - capsules modified release - 200/25 mg/mg - platelet aggregation inhibitors excl. heparin
asasantin retard 200/25 milligram capsules modified release
pco manufacturing - dipyridamole acetylsalicylic acid - capsules modified release - 200/25 milligram